Asturias Cardiologist Leads First AI-Guided Angioplasty in Spain
Carmen Liedo, a prominent cardiologist from the Central University Hospital of Asturias (HUCA), recently directed the first angioplasty in Spain guided by artificial intelligence (AI). This groundbreaking intervention marks a significant advancement in the field of cardiology and sets a new standard for optimizing patient care.
In a recent interview, Cesar Morís, head of the Heart Unit at HUCA, emphasized the importance of AI-based tools in cardiology. He highlighted the benefits of using AI to better characterize coronary diseases and injuries, ultimately leading to more informed treatment decisions that benefit the patient in the long term.
The successful implementation of AI-guided angioplasties at HUCA signifies a major milestone in cardiovascular care. This innovative approach provides cardiologists with advanced information about the composition of atheromatous plaques, helping them tailor treatment strategies for each patient’s specific needs.
Morís underscored the high success rates of interventions performed with AI-based systems, with success rates exceeding 90% in immediate outcomes. However, he emphasized the importance of optimizing long-term treatment results and ensuring the continued well-being of patients.
The integration of artificial intelligence into cardiology represents a major step forward in the evolution of medicine. Morís believes that AI will revolutionize the way healthcare is delivered in the coming decades, but he also stresses the importance of human supervision in utilizing AI tools effectively.
As the first hospital in Spain to conduct AI-guided angioplasties, HUCA has set a new standard for patient care and technological innovation in cardiology. Morís expressed pride in the accomplishments of his team and highlighted the positive impact on patient outcomes as a result of AI-enhanced procedures.
Looking to the future, Morís envisions a transformative impact of artificial intelligence on the practice of medicine, not only in cardiology but across all medical specialties. While AI has the potential to enhance diagnostic and therapeutic capabilities, Morís believes that a collaborative approach between AI systems and healthcare professionals is essential for optimal patient care.
In conclusion, the successful implementation of AI-guided angioplasties at HUCA exemplifies the intersection of cutting-edge technology and compassionate healthcare, setting a new standard for cardiovascular interventions in Spain and beyond.